Patents by Inventor Stephen Zolla

Stephen Zolla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for delivering drugs to an eye
    Patent number: 10342697
    Abstract: A drug delivery device includes a drug-eluting element defined by a plurality of outer surfaces including a delivery surface and one or more other non-delivery surfaces. The delivery surface is positioned against tissue of an eye and shaped to define an area of targeted tissue to receive a drug. The drug-eluting element holds the drug when the delivery surface is not positioned against the tissue. Responsive to the delivery surface being positioned against the tissue, the drug-eluting element releases the drug to the area of targeted tissue through the delivery surface. The drug delivery device includes one or more barrier structures disposed along the one or more non-delivery surfaces of the drug-eluting element. The one or more barrier structures substantially inhibit release of the drug from the drug-eluting element through the one or more non-delivery surfaces.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: July 9, 2019
    Assignee: Avedro, Inc.
    Inventors: Marc D. Friedman, Pavel Kamaev, Stephen Zolla, Alexandra Nicklin
  • SYSTEMS AND METHODS FOR DELIVERING DRUGS TO AN EYE
    Publication number: 20170296383
    Abstract: A drug delivery device includes a drug-eluting element defined by a plurality of outer surfaces including a delivery surface and one or more other non-delivery surfaces. The delivery surface is positioned against tissue of an eye and shaped to define an area of targeted tissue to receive a drug. The drug-eluting element holds the drug when the delivery surface is not positioned against the tissue. Responsive to the delivery surface being positioned against the tissue, the drug-eluting element releases the drug to the area of targeted tissue through the delivery surface. The drug delivery device includes one or more barrier structures disposed along the one or more non-delivery surfaces of the drug-eluting element. The one or more barrier structures substantially inhibit release of the drug from the drug-eluting element through the one or more non-delivery surfaces.
    Type: Application
    Filed: April 13, 2017
    Publication date: October 19, 2017
    Inventors: Marc D. Friedman, Pavel Kamaev, Stephen Zolla, Alexandra Nicklin